PMID- 29187211 OWN - NLM STAT- MEDLINE DCOM- 20180727 LR - 20190221 IS - 1477-7819 (Electronic) IS - 1477-7819 (Linking) VI - 15 IP - 1 DP - 2017 Nov 29 TI - Roles of KAI1 and nm23 in lymphangiogenesis and lymph metastasis of laryngeal squamous cell carcinoma. PG - 211 LID - 10.1186/s12957-017-1279-0 [doi] LID - 211 AB - BACKGROUND: Lymphatic metastasis contributes to the poor prognosis of laryngeal squamous cell carcinoma (LSCC). This study aimed to investigate the roles of two metastasis suppressor genes, KAI1 and nm23, in lymphangiogenesis and lymph metastasis of LSCC. METHODS: A total of 45 LSCC patients were enrolled in this study. The positive expression rates of KAI1 and nm23 protein were detected via immunohistochemistry in 45 LSCC and 22 normal laryngeal mucosa adjacent to LSCC. Micro-lymphatic vessel density (MLVD) was detected via immunohistochemistry with the specific antibody D2-40. Associations between KAI1 and nm23 expression and clinical characteristics of LSCC were then evaluated. RESULTS: The positive expression rates of KAI1 and nm23 were significantly lower in LSCC than normal laryngeal mucosa (P < 0.05). Significantly lower positive rates of KAI1 and nm23 were found in LSCC with lymphatic metastasis than those without lymphatic metastasis (P < 0.05), whereas MLVD was negatively correlated with the expression of KAI1 and nm23 (P < 0.05). However, no significant associations were found between KAI1 and nm23 expression and clinical characteristics of LSCC (sex, age, disease position, differentiation, and T-stage). CONCLUSIONS: Both KAI1 and nm23 can inhibit lymphangiogenesis and lymphatic metastasis in LSCC. FAU - Zheng, Zongzhu AU - Zheng Z AD - Department of Otorhinolaryngology, Taian City Central Hospital, Taian, Shandong, 271000, China. FAU - Tian, Ruihua AU - Tian R AD - Department of Medical Oncology, Taian City Central Hospital, No. 29 Longtan Road, Taishan District, Taian, Shandong, 271000, China. tianruihua0306@hotmail.com. FAU - Wang, Ping AU - Wang P AD - Department of Geriatrics, Taian City Central Hospital, Taian, Shandong, 271000, China. LA - eng PT - Journal Article DEP - 20171129 PL - England TA - World J Surg Oncol JT - World journal of surgical oncology JID - 101170544 RN - 0 (Biomarkers, Tumor) RN - 0 (CD82 protein, human) RN - 0 (Kangai-1 Protein) RN - 0 (NM23 Nucleoside Diphosphate Kinases) RN - EC 2.7.4.6 (NME1 protein, human) SB - IM MH - Biomarkers, Tumor/metabolism MH - Carcinoma, Squamous Cell/*pathology MH - Female MH - Head and Neck Neoplasms/*pathology MH - Humans MH - Immunohistochemistry MH - Kangai-1 Protein/*metabolism MH - Laryngeal Mucosa/pathology MH - Laryngeal Neoplasms/*pathology MH - *Lymphangiogenesis MH - Lymphatic Metastasis MH - Male MH - Middle Aged MH - NM23 Nucleoside Diphosphate Kinases/*metabolism MH - Prognosis MH - Squamous Cell Carcinoma of Head and Neck PMC - PMC5707808 OTO - NOTNLM OT - KAI1 OT - Laryngeal squamous cell carcinoma OT - Lymphangiogenesis OT - Lymphatic metastasis OT - nm23 COIS- ETHICS APPROVAL AND CONSENT TO PARTICIPATE: This study was approved by the local Institutional Review Board, and informed consent was obtained from all subjects. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER'S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. EDAT- 2017/12/01 06:00 MHDA- 2018/07/28 06:00 PMCR- 2017/11/29 CRDT- 2017/12/01 06:00 PHST- 2017/02/17 00:00 [received] PHST- 2017/11/15 00:00 [accepted] PHST- 2017/12/01 06:00 [entrez] PHST- 2017/12/01 06:00 [pubmed] PHST- 2018/07/28 06:00 [medline] PHST- 2017/11/29 00:00 [pmc-release] AID - 10.1186/s12957-017-1279-0 [pii] AID - 1279 [pii] AID - 10.1186/s12957-017-1279-0 [doi] PST - epublish SO - World J Surg Oncol. 2017 Nov 29;15(1):211. doi: 10.1186/s12957-017-1279-0.